The project is valued at approximately ₹3,000 crore, including projected operating income over the concession period. The project will be executed on a Public-Private Partnership (PPP) basis under the Design, Build, Finance, Operate, and Transfer (DBFOT) model.
The concession spans 95 years, including a five-year construction phase. The construction portion, expected to be executed in the next five years, will form part of Ramky Infrastructure’s order book, taking it to around ₹13,500 crore.
Also Read: Ramky Infrastructure wins ₹1,402 crore EPC contract for Dighi Port Industrial Area Project
The pharmaceutical park will be developed across roughly 1,000 hectares covering parts of Mangaon and Roha talukas. It will feature industrial zones, commercial areas, common infrastructure, utilities, internal roads, and designated open spaces.
The project is designed to create an integrated life sciences manufacturing ecosystem with advanced infrastructure, innovation-focused R&D centres, incubation hubs, and technology transfer platforms. Environmental responsibility, regulatory compliance, and sustainable operations are key components of the development.
Under the concession agreement, MILeS City will manage development, operations, maintenance, and management of the park for the entire concession period. Revenue will be generated through land lease premiums, lease rentals, development and maintenance charges, and operational charges for utilities and shared facilities.
Also Read: Ramky Infra shares rally after ₹2,085 crore order win, 50% of its market cap
The project is expected to boost industrial infrastructure in the region, attract investment in the pharmaceutical and life sciences sectors, create direct and indirect employment opportunities, and stimulate growth in ancillary industries and local businesses.
Sunil S Nair, CEO, Ramky Infrastructure Ltd, said, “This agreement marks a significant milestone not only for industrial development, but for the wider communities and businesses that stand to benefit from it.
By creating a large-scale integrated life sciences ecosystem at Dighi Port Industrial Area, we see an opportunity to support employment generation, strengthen regional infrastructure, encourage innovation, and attract long-term investment into Maharashtra.
The project is designed to enable pharmaceutical and biotechnology companies to grow within a well-supported and globally competitive manufacturing environment.”
Also Read: Ramky Infra secures ₹215 crore contract for sewage treatment plants in Hyderabad
Shares of Ramky Infrastructure Ltd ended at ₹480.25, up by ₹22.20, or 4.85%, on the BSE.
